Twist Bioscience Corporation
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Dec 2017 | $-16.0M | $-17.5M | $1.5M | $536.0K |
| Mar 2018 | $-16.5M | $-17.0M | $501.0K | $736.0K |
| Jun 2018 | $-16.9M | $-17.6M | $629.0K | $603.0K |
| Sep 2018 | $-16.7M | $-17.7M | $1.0M | $1.1M |
| Dec 2018 | $-21.7M | $-23.6M | $1.9M | $1.9M |
| Mar 2019 | $-20.8M | $-24.6M | $3.8M | $2.9M |
| Jun 2019 | $-22.1M | $-27.3M | $5.2M | $3.0M |
| Sep 2019 | $-23.4M | $-27.3M | $3.9M | $3.4M |
| Dec 2019 | $-34.9M | $-37.0M | $2.1M | $3.7M |
| Mar 2020 | $-58.7M | $-61.4M | $2.7M | $4.2M |
| Jun 2020 | $-23.5M | $-26.3M | $2.8M | $4.1M |
| Sep 2020 | $-25.2M | $-27.4M | $2.2M | $5.1M |
| Dec 2020 | $-24.9M | $-28.6M | $3.6M | $7.0M |
| Mar 2021 | $-24.5M | $-33.0M | $8.4M | $11.6M |
| Jun 2021 | $-28.0M | $-34.9M | $6.9M | $9.2M |
| Sep 2021 | $-34.8M | $-42.9M | $8.1M | $9.2M |
| Dec 2021 | $-46.7M | $-59.4M | $12.8M | $18.1M |
| Mar 2022 | $-42.3M | $-74.3M | $32.0M | $22.5M |
| Jun 2022 | $-34.1M | $-74.8M | $40.6M | $20.0M |
| Sep 2022 | $-1.3M | $-17.7M | $16.5M | $19.0M |
| Dec 2022 | $-54.1M | $-65.9M | $11.8M | $-2.3M |
| Mar 2023 | $-44.3M | $-53.3M | $9.1M | $10.3M |
| Jun 2023 | $-23.4M | $-27.9M | $4.5M | $10.6M |
| Sep 2023 | $-20.7M | $-23.1M | $2.4M | $11.7M |
| Dec 2023 | $-23.0M | $-24.5M | $1.5M | $11.0M |
| Mar 2024 | $-19.4M | $-20.0M | $603.0K | $13.8M |
| Jun 2024 | $-6.4M | $-7.3M | $965.0K | $13.7M |
| Sep 2024 | $-15.3M | $-17.3M | $2.0M | $12.3M |
| Dec 2024 | $-21.4M | $-23.7M | $2.3M | $12.0M |
| Mar 2025 | $-13.0M | $-17.1M | $4.1M | $20.3M |
| Jun 2025 | $-1.4M | $-10.6M | $9.2M | $16.1M |
| Sep 2025 | $-11.8M | $-24.2M | $12.4M | $16.1M |
| Dec 2025 | $-24.8M | $-34.8M | $10.0M | $13.3M |
| Mar 2026 | $-17.6M | $-25.4M | $7.9M | $18.9M |
| Jun 2026 | $1.1M | $-8.6M | $9.8M | $18.2M |